会社概要
- 正式社名: Chengdu Yacht Bio-technology Co., Ltd
- 登録国: China
- 住所: No.7 Mansion, Tianfu Life Science Park, South Keyu, Chengdu • Sichuan
- 従業員数: 100 - 249
- 設立年: 2004
説明:
Chengdu Yacht Bio-technology is engaged in the R&D, production and sales of APIs, biological drugs and intermediates across therapeutic fields including anti-tumor, anti-infective and immune system treatments. Its subsidiary, Sichuan Novals Pharmaceuticals, upholds a quality-and-service-first principle to provide high-quality products and solutions, with main products including daptomycin, micafungin, caspofungin, everolimus, dalbavancin and anidulafungin.
事業活動
生物由来・発酵原料
製造業者
原薬(API)
原薬メーカー
先発品原薬
原薬メーカー
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany
当社の製品・サービス
認証
証明
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す